发明名称 NITROGENOUS-RING ACYLGUANIDINE DERIVATIVE
摘要 [Object] An excellent agent for preventing or treating dementia, schizophrenia, and the like, based on serotonin 5-HT 5A receptor modulating action, is provided. [Means for Solution] It was confirmed that acylguanidine derivatives which have the characteristic structure in which the guanidine is bonded to one ring of the quinoline or isoquinoline via a carbonyl group, and a cyclic group is bonded to the other ring, exhibit potent 5-HT 5A receptor modulating actions and excellent pharmacological actions based on said 5-HT 5A receptor modulating action, and thus can be excellent agents for preventing or treating dementia, schizophrenia, bipolar disorder, or attention deficit hyperactivity disorder. Thus, the present invention has been completed.
申请公布号 EP2463276(A4) 申请公布日期 2013.02.13
申请号 EP20100806503 申请日期 2010.08.05
申请人 ASTELLAS PHARMA INC. 发明人 KINOYAMA, ISAO;MIYAZAKI, TAKEHIRO;KOGANEMARU, YOHEI;WASHIO, TAKUYA;HAMAGUCHI, WATARU
分类号 C07D215/48;A61K31/47;A61K31/4709;A61K31/472;A61K31/4725;A61P25/00;A61P25/18;A61P25/28;A61P43/00;C07D215/54;C07D215/60;C07D217/02;C07D217/14;C07D217/16;C07D217/22;C07D401/04 主分类号 C07D215/48
代理机构 代理人
主权项
地址
您可能感兴趣的专利